• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . Machine learning-enhanced immunopeptidomics applied to T-cell epitope discovery for COVID-19 vaccines

tetano

Editor, Senior Moderator
Nat Commun


. 2024 Nov 28;15(1):10316.
doi: 10.1038/s41467-024-54734-9. Machine learning-enhanced immunopeptidomics applied to T-cell epitope discovery for COVID-19 vaccines

Kevin A Kovalchik[SUP] #[/SUP][SUP] 1 [/SUP], David J Hamelin[SUP] #[/SUP][SUP] 1 2 3 4 [/SUP], Peter Kubiniok[SUP] #[/SUP][SUP] 1 [/SUP], Benoîte Bourdin[SUP] 1 [/SUP], Fatima Mostefai[SUP] 2 3 4 [/SUP], Raphaël Poujol[SUP] 2 [/SUP], Bastien Paré[SUP] 1 [/SUP], Shawn M Simpson[SUP] 1 [/SUP], John Sidney[SUP] 5 [/SUP], Éric Bonneil[SUP] 6 [/SUP], Mathieu Courcelles[SUP] 6 [/SUP], Sunil Kumar Saini[SUP] 7 [/SUP], Mohammad Shahbazy[SUP] 8 [/SUP], Saketh Kapoor[SUP] 9 [/SUP], Vigneshwar Rajesh[SUP] 9 [/SUP], Maya Weitzen[SUP] 9 [/SUP], Jean-Christophe Grenier[SUP] 2 [/SUP], Bayrem Gharsallaoui[SUP] 1 [/SUP], Loïze Maréchal[SUP] 1 [/SUP], Zhaoguan Wu[SUP] 1 [/SUP], Christopher Savoie[SUP] 1 [/SUP], Alessandro Sette[SUP] 5 [/SUP], Pierre Thibault[SUP] 6 10 [/SUP], Isabelle Sirois[SUP] 1 [/SUP], Martin A Smith[SUP] 1 4 [/SUP], Hélène Decaluwe[SUP] 1 11 12 [/SUP], Julie G Hussin[SUP] 13 14 15 16 [/SUP], Mathieu Lavallée-Adam[SUP] 17 18 [/SUP], Etienne Caron[SUP] 19 20 21 [/SUP]



Affiliations
Abstract

Next-generation T-cell-directed vaccines for COVID-19 focus on establishing lasting T-cell immunity against current and emerging SARS-CoV-2 variants. Precise identification of conserved T-cell epitopes is critical for designing effective vaccines. Here we introduce a comprehensive computational framework incorporating a machine learning algorithm-MHCvalidator-to enhance mass spectrometry-based immunopeptidomics sensitivity. MHCvalidator identifies unique T-cell epitopes presented by the B7 supertype, including an epitope from a + 1-frameshift in a truncated Spike antigen, supported by ribosome profiling. Analysis of 100,512 COVID-19 patient proteomes shows Spike antigen truncation in 0.85% of cases, revealing frameshifted viral antigens at the population level. Our EpiTrack pipeline tracks global mutations of MHCvalidator-identified CD8 + T-cell epitopes from the BNT162b4 vaccine. While most vaccine epitopes remain globally conserved, an immunodominant A*01-associated epitope mutates in Delta and Omicron variants. This work highlights SARS-CoV-2 antigenic features and emphasizes the importance of continuous adaptation in T-cell vaccine development.


 
Back
Top Bottom